Ann P Murchison1, David S Friedman2, Emily W Gower2,3, Julia A Haller1, Byron L Lam4, David J Lee4, Gerald McGwin5,6, Cynthia Owsley5, Jinan Saaddine7. 1. a Wills Eye Hospital , Thomas Jefferson University , Philadelphia , PA , USA. 2. b Dana Center for Preventive Ophthalmology , Johns Hopkins Hospital , Baltimore , MD , USA. 3. c Departments of Epidemiology and Prevention, and Ophthalmology , Wake Forest School of Medicine , Winston-Salem , NC , USA. 4. d Department of Public Health Sciences , University of Miami Miller School of Medicine , Miami , FL , USA. 5. e Department of Ophthalmology , University of Alabama at Birmingham , Birmingham , AL , USA. 6. f Department of Epidemiology , University of Alabama at Birmingham , Birmingham , AL , USA. 7. g Division of Diabetes Translation , Centers for Disease Control and Prevention , Atlanta , GA , USA.
Abstract
PURPOSE: Diabetes is the leading cause of new cases of blindness among adults aged 20-74 years within the United States. The Innovative Network for Sight Research group (INSIGHT) designed the Diabetic Eye Screening Study (DESS) to examine the feasibility and short-term effectiveness of non-mydriatic diabetic retinopathy (DR) screening for adults with diabetes in community-based settings. METHODS: Study enrollment began in December 2011 at four sites: an internal medicine clinic at a county hospital in Birmingham, Alabama; a Federally-qualified community healthcare center in Miami-Dade County, Florida; a university-affiliated outpatient pharmacy in Philadelphia, Pennsylvania; and a medical home in Winston-Salem, North Carolina. People 18 years or older with previously diagnosed diabetes were offered free DR screening using non-mydriatic retinal photography that was preceded by a brief questionnaire addressing demographic information and previous eye care use. Visual acuity was also measured for each eye. Images were evaluated at a telemedicine reading center by trained evaluators using the National Health System DR grading classification. Participants and their physicians were sent screening report results and telephoned for a follow-up survey 3 months post-screening to determine whether participants had sought follow-up comprehensive eye care and their experiences with the screening process. RESULTS: Target enrollment at each site was a minimum of 500 persons. Three of the four sites met this enrollment goal. CONCLUSION: The INSIGHT/DESS is intended to establish the feasibility and short-term effectiveness of DR screening using non-mydriatic retinal photography in persons with diabetes who seek services in community-based clinic and pharmacy settings.
PURPOSE:Diabetes is the leading cause of new cases of blindness among adults aged 20-74 years within the United States. The Innovative Network for Sight Research group (INSIGHT) designed the Diabetic Eye Screening Study (DESS) to examine the feasibility and short-term effectiveness of non-mydriatic diabetic retinopathy (DR) screening for adults with diabetes in community-based settings. METHODS: Study enrollment began in December 2011 at four sites: an internal medicine clinic at a county hospital in Birmingham, Alabama; a Federally-qualified community healthcare center in Miami-Dade County, Florida; a university-affiliated outpatient pharmacy in Philadelphia, Pennsylvania; and a medical home in Winston-Salem, North Carolina. People 18 years or older with previously diagnosed diabetes were offered free DR screening using non-mydriatic retinal photography that was preceded by a brief questionnaire addressing demographic information and previous eye care use. Visual acuity was also measured for each eye. Images were evaluated at a telemedicine reading center by trained evaluators using the National Health System DR grading classification. Participants and their physicians were sent screening report results and telephoned for a follow-up survey 3 months post-screening to determine whether participants had sought follow-up comprehensive eye care and their experiences with the screening process. RESULTS: Target enrollment at each site was a minimum of 500 persons. Three of the four sites met this enrollment goal. CONCLUSION: The INSIGHT/DESS is intended to establish the feasibility and short-term effectiveness of DR screening using non-mydriatic retinal photography in persons with diabetes who seek services in community-based clinic and pharmacy settings.
Entities:
Keywords:
Diabetes; eye screening; methodology; study design; tele-ophthalmology
Authors: Donald S Fong; Lloyd Aiello; Thomas W Gardner; George L King; George Blankenship; Jerry D Cavallerano; Fredrick L Ferris; Ronald Klein Journal: Diabetes Care Date: 2003-01 Impact factor: 19.112
Authors: Nathan Congdon; Johannes R Vingerling; Barbara E K Klein; Sheila West; David S Friedman; John Kempen; Benita O'Colmain; Suh-Yuh Wu; Hugh R Taylor Journal: Arch Ophthalmol Date: 2004-04
Authors: John H Kempen; Benita J O'Colmain; M Cristina Leske; Steven M Haffner; Ronald Klein; Scot E Moss; Hugh R Taylor; Richard F Hamman Journal: Arch Ophthalmol Date: 2004-04
Authors: S Harding; R Greenwood; S Aldington; J Gibson; D Owens; R Taylor; E Kohner; P Scanlon; G Leese Journal: Diabet Med Date: 2003-12 Impact factor: 4.359
Authors: Cynthia Owsley; Gerald McGwin; David J Lee; Byron L Lam; David S Friedman; Emily W Gower; Julia A Haller; Lisa A Hark; Jinan Saaddine Journal: JAMA Ophthalmol Date: 2015-02 Impact factor: 7.389
Authors: Jose R Davila; Sabyasachi S Sengupta; Leslie M Niziol; Manavi D Sindal; Cagri G Besirli; Swati Upadhyaya; Maria A Woodward; Rengaraj Venkatesh; Alan L Robin; Joseph Grubbs; Paula Anne Newman-Casey Journal: Ophthalmologica Date: 2017-07-05 Impact factor: 3.250